| Ytd | -99.02% | |
| 1y | -99.60% |
| Open | 4.56 | Prev Close | 4.53 | Low | 4.47 | High | 5.33 | Mkt Cap | 9.32M |
| Vol | 1.09M | Avg Vol | 2.01M | EPS | -4204.98 | P/E | N/A | Forward P/E | -0.37 |
| Beta | 0.88 | Short Ratio | 1.12 | Inst. Own | 1.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 9.92 | 200-d Avg | 162.16 | 1yr Est | 6.00 |
JAGX News
Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares moved upwards by 52.5% to $7.0 during Tuesday
Company remains sharply focused on its ongoing rare disease intestinal failure global development pr
Gainers Jaguar Health (NASDAQ:JAGX) stock moved upwards by 34.0% to $6.34 during Tuesday's pre-
Option Care Health jumped 23.8% on reports McKesson and CD&R may acquire it; Freight Technologie
Jaguar Health shares surged 34.67% after hours Monday following the company’s special dividend annou
Gainers HeartBeam (NASDAQ:BEAT) stock moved upwards by 70.5% to $0.74 during Monday's regular s
Gainers Apimeds Pharmaceuticals (AMEX:APUS) stock moved upwards by 76.7% to $5.69 during Monday'
PTC jumped 34.7% after Schneider Electric offered $22.6B; Columbus Acquisition soared 657.5%, while
Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluat
Company remains sharply focused on its ongoing rare disease intestinal failure global development pr
A rare-disease pipeline update and a thin post-split float are combining to send Jaguar Health (NASD
Jaguar Health Inc. (NASDAQ:JAGX) shares are surging Friday morning, reversing Thursday's dilution-dr
Jaguar Health is surging Friday after announcing debt-for-equity exchanges that cut debt by over $6.
Jaguar Health Inc. (NASDAQ:JAGX) shares are sliding Thursday afternoon as equity dilution concerns w
Jaguar Health shares are sliding Thursday as equity dilution concerns weigh on the company following
Two biotech names are moving sharply lower Thursday morning while the sector benchmark grinds higher
As previously disclosed, on November 12, 2025, Jaguar Health, Inc. (the "Company") issued an
JAGUAR HEALTH, INC.Up to $9,824,188Shares of Common Stock This supplement No. 8 (this "Supplemen
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after
Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 216.1% to $13.12 during Wednesday's regula
Two biotechnology names are lower in Wednesday morning trading for unrelated reasons, and the biotec
Jaguar Health Inc. (NASDAQ:JAGX) shares are plunging Wednesday morning as profit-taking reverses an
Jaguar Health shares are plunging Wednesday morning as profit-taking reverses an explosive Tuesday r
U.S. stocks fell Wednesday; General Mills beat estimates, energy rose, utilities declined, while oil
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market sessi
U.S. futures edged higher; InnovAge fell 9.4% after a 10M-share offering. Jaguar Health, Voyager Tec
Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REI
Jaguar Health shares jumped 5.19% after hours following FDA fee waivers for two of its commercialize
JAGX, IONQ, VKTX, XNDU, GRAB were among the stocks seen trending on Tuesday, Sept. 22, 2026.
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 32.2% to $45.56 during Tuesday's af
Gainers Jaguar Health (NASDAQ:JAGX) stock increased by 304.5% to $10.8 during Tuesday's regular
Company remains sharply focused on its ongoing rare disease intestinal failure global development pr
Company remains sharply focused on its ongoing rare disease intestinal failure global development pr
Reverse split approved at April 2026 Special Meeting of StockholdersShares of Jaguar Health common s
Reverse split approved at April 2026 Special Meeting of Stockholders Shares of Jaguar Health common
Shares of Jaguar Health Inc. (NASDAQ:JAGX) are trading lower Thursday morning as investors evaluate
Jaguar Health is trading lower Thursday as investors weigh the clinical timeline for its rare pediat
Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announce
Continuation of treatment with blinded doses of crofelemer in the extension phase of the trial will
Gainers Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market s
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market
Gainers Immuron (NASDAQ:IMRN) shares moved upwards by 48.2% to $1.65 during Friday's regular se
Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adju
Gainers Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 8.2% to $2.63 during Tuesday
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the initiation of the commercia
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide
Jaguar Health, Inc. (JAGX) Q2 2026 Earnings Call Prepared Remarks Transcript
Jaguar Health (NASDAQ:JAGX) released second-quarter financial results and hosted an earnings call on
Company remains sharply focused on its ongoing global development program for crofelemer for rare in